Copyright
©The Author(s) 2015.
World J Clin Cases. Dec 16, 2015; 3(12): 1005-1010
Published online Dec 16, 2015. doi: 10.12998/wjcc.v3.i12.1005
Published online Dec 16, 2015. doi: 10.12998/wjcc.v3.i12.1005
Figure 2 Clinical course of a patient with concomitant deterioration of hepatic reserve and renal function due to combination treatment with daclatasvir and asunaprevir.
HCV: Hepatitis C virus; EBV: Epstein-Barr virus.
- Citation: Suga T, Sato K, Yamazaki Y, Ohyama T, Horiguchi N, Kakizaki S, Kusano M, Yamada M. Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevir. World J Clin Cases 2015; 3(12): 1005-1010
- URL: https://www.wjgnet.com/2307-8960/full/v3/i12/1005.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v3.i12.1005